Home/Siolta Therapeutics/Dr. Ricardo Valladares
DR

Dr. Ricardo Valladares

Scientific Leadership (inferred)

Siolta Therapeutics

Siolta Therapeutics Pipeline

DrugIndicationPhase
STMC-103HPrevention of Atopic Dermatitis in high-risk infantsPhase 2
Undisclosed LBPPrevention of Necrotizing Enterocolitis (NEC)Preclinical